# Study of 5-FU + Leucovorin + CPT-11 in Patients With Resectable Liver Metastases From Colorectal Adenocarcinoma

> **NCT00168155** · PHASE2 · COMPLETED · sponsor: **Alberta Health services** · enrollment: 70 (—)

## Conditions studied

- Colorectal Adenocarcinoma
- Liver Metastases

## Interventions

- **DRUG:** perioperative chemotherapy

## Key facts

- **NCT ID:** NCT00168155
- **Lead sponsor:** Alberta Health services
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-01
- **Primary completion:** 2009-05
- **Final completion:** 2009-05
- **Target enrollment:** 70 (—)
- **Last updated:** 2012-01-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00168155

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00168155, "Study of 5-FU + Leucovorin + CPT-11 in Patients With Resectable Liver Metastases From Colorectal Adenocarcinoma". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT00168155. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*